*Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara; †Section of Translational Research, Hyogo Cancer Center, Akashi, Hyogo; ‡Department of Pathology, Nara Medical University, Kashihara, Nara; and §Department of Obstetrics and Gynecology, Yao Municipal Hospital, Yao-city, Osaka, Japan.
Int J Gynecol Cancer. 2014 Jun;24(5):838-43. doi: 10.1097/IGC.0000000000000136.
Appropriate cell cycle checkpoints are essential for the maintenance of normal cells and chemosensitivity of cancer cells. Clear cell adenocarcinoma (CCA) of the ovary is highly resistant to chemotherapy. Hepatocyte nuclear factor-1β (HNF-1β) is known to be overexpressed in CCA, but its role and clinical significance is unclear. We investigated the role of HNF-1β in regulation of the cell cycle in CCA.
To clarify the effects of HNF-1β on cell cycle checkpoints, we compared the cell cycle distribution and the expression of key proteins involved in CCA cells in which HNF-1β had been stably knocked down and in vector-control cell lines after treatment with bleomycin. HNF-1β (+) cells were arrested in G2 phase because of DNA damage.
HNF-1β (-) cells died because of a checkpoint mechanism. G2 arrest of HNF-1β (+) cells resulted from sustained CHK1 activation, a protein that plays a major role in the checkpoint mechanism. HNF-1β (+) cells were treated with a CHK1 inhibitor after bleomycin treatment. Flow cytometric analysis of the cell cycle demonstrated that DNA damage-induced G2-arrested cells were released from the checkpoint and killed by a CHK1 inhibitor.
The chemoresistance of CCA may be due to aberrant retention of the G2 checkpoint through overexpression of HNF-1β. This is the first study demonstrating cell cycle regulation and chemosensitization by a CHK1 inhibitor in CCA.
适当的细胞周期检查点对于维持正常细胞和癌细胞的化疗敏感性至关重要。卵巢透明细胞腺癌(CCA)对化疗具有高度耐药性。已知肝细胞核因子-1β(HNF-1β)在 CCA 中过度表达,但它的作用和临床意义尚不清楚。我们研究了 HNF-1β在调节 CCA 细胞周期中的作用。
为了阐明 HNF-1β对细胞周期检查点的影响,我们比较了 HNF-1β稳定敲低的 CCA 细胞和载体对照细胞系在博来霉素处理后细胞周期分布和关键蛋白表达的变化。由于 DNA 损伤,HNF-1β(+)细胞被阻滞在 G2 期。
HNF-1β(-)细胞由于检查点机制而死亡。HNF-1β(+)细胞的 G2 期阻滞是由于持续的 CHK1 激活所致,CHK1 是检查点机制中的主要蛋白。用 CHK1 抑制剂处理 HNF-1β(+)细胞后,对细胞周期进行流式细胞术分析表明,DNA 损伤诱导的 G2 期阻滞细胞通过 CHK1 抑制剂从检查点释放并被杀死。
CCA 的化疗耐药性可能是由于 HNF-1β的过度表达导致 G2 检查点异常保留。这是第一项研究表明 CHK1 抑制剂在 CCA 中调节细胞周期和增敏作用。